By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CardioDx, Inc. 

2500 Faber Place

Palo Alto  California  94303  U.S.A.
Phone: 650-475-2788 Fax: 650-475-2799


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
CardioDx, Inc. Announces Results Of Study Demonstrating The Benefits Of The Corus CAD Gene Expression Test Use In An African American Patient Population 10/21/2014 1:14:58 PM
CardioDx, Inc. Announces Results Of Study Demonstrating The Benefits Of The Corus CAD Gene Expression Test Use In An African American Patient Population 10/20/2014 10:08:26 AM
Redwood City's CardioDx, Inc. Bags $21 Million As Biotech IPOs Hit Rough Patch 7/25/2014 6:59:27 AM
CardioDx, Inc. Announces Aetna And Coventry Health Coverage For Corus® CAD Gene Expression Test 7/8/2014 11:49:52 AM
CardioDx, Inc. Release: New Study Results Further Reinforce That The Corus® CAD Test Helps Primary Care Clinicians Make Effective Referral Decisions For Patients With Suspected Obstructive Coronary Artery Disease 5/5/2014 9:52:05 AM
CardioDx, Inc. Resurrects IPO Dreams 4/30/2014 8:18:29 AM
CardioDx, Inc. Announces New Leadership Appointments 4/28/2014 5:13:27 PM
CardioDx, Inc. And Medison Israel Enter Into An Exclusive Corus® CAD Product Marketing And Sales Agreement 4/9/2014 9:41:33 AM
CardioDx, Inc. Release: Study Finds the Corus® CAD Gene Expression Blood Test Influenced Primary Care Decision-Making In The Assessment Of Patients With Suspected Obstructive Coronary Artery Disease 3/11/2014 10:04:37 AM
CardioDx, Inc. Release: The Corus® CAD Gene Expression Test Can Help Commercial Health Plans Reduce Costs By Improving The Accuracy Of The Diagnostic Workup In Patients With Suspected Obstructive Coronary Artery Disease 2/26/2014 12:58:21 PM
123456
//-->